Chin-shiou Huang
Vice President & Chief Technology Officer
biotechnology
PlexBio
Taiwan
Biography
Dr. Huang has over 20 years of research experience in areas related to biotechnology. In 1999, he invented an artificial antibody fabrication technology and co-founded Aspira Biosystems. Dr. Huang led an advanced research team that applied the a-state-of-the-art artificial antibody technology to protein capture mechanism in many platforms, such as sequence-specific protein capture beads and protein capture array chips. Aspira was funded by Alloy Ventures and later acquired by Nanomune Inc. He received his Ph.D. in Biochemistry and Molecular Biology from Cornell University.
Research Interest
artificial antibody technology to protein capture mechanism in many platforms, such as sequence-specific protein capture beads and protein capture array chips
